References
1-Chatrath, N., et al., The effect of concomitant COVID-19 infection on
outcomes in patients hospitalized with heart failure. ESC heart failure,
2020. 7 (6): p. 4443-4447.
2 Varghese, G.M., et al., Clinical management of COVID-19. The Indian
journal of medical research, 2020. 151 (5): p. 401-410.
3-Cheruiyot, I., et al., Arterial Thrombosis in Coronavirus Disease 2019
Patients: A Rapid Systematic Review. Annals of vascular surgery, 2021.70 : p. 273-281.
4-McBane, R.D., 2nd, Arterial Thrombosis and Coronavirus Disease 2019.
Mayo Clinic proceedings, 2021. 96 (2): p. 274-276.
5-Burn, E., et al., Venous or arterial thrombosis and deaths among
COVID-19 cases: a European network cohort study. Lancet Infect Dis,
2022.
6-Gold, D.D., R. Kurd, and S. Einav, Don’t forget arterial thrombosis in
patients with COVID-19: A case series. Thrombosis Update, 2021.5 : p. 100065.
7-Levi, M., et al., Coagulation abnormalities and thrombosis in patients
with COVID-19. Lancet Haematol, 2020. 7 (6): p. e438-e440.
8-Abou-Ismail, M.Y., et al., The hypercoagulable state in COVID-19:
Incidence, pathophysiology, and management. Thrombosis research, 2020.194 : p. 101-115.
9-Kubánková, M., et al., Physical phenotype of blood cells is altered in
COVID-19. Biophysical journal, 2021. 120 (14): p. 2838-2847.
10-Whyte, C.S., et al., Fibrinolytic abnormalities in acute respiratory
distress syndrome (ARDS) and versatility of thrombolytic drugs to treat
COVID-19. J Thromb Haemost, 2020. 18 (7): p. 1548-1555.
11-Roberts, K.A., et al., Vascular Manifestations of COVID-19 -
Thromboembolism and Microvascular Dysfunction. Frontiers in
cardiovascular medicine, 2020. 7 : p. 598400-598400.
12-Whitson, B.A., et al., Hemolysis, pump thrombus, and neurologic
events in continuous-flow left ventricular assist device recipients. Ann
Thorac Surg, 2014. 97 (6): p. 2097-103.
13-Fatullayev, J., et al., Continuous-Flow Left Ventricular Assist
Device Thrombosis: A Danger Foreseen is a Danger Avoided. Medical
science monitor basic research, 2015. 21 : p. 141-144.
14-Dang, G., et al., Medical Management of Pump-Related Thrombosis in
Patients with Continuous-Flow Left Ventricular Assist Devices: A
Systematic Review and Meta-Analysis. Asaio j, 2017. 63 (4): p.
373-385.
15-Upshaw, J.N., et al., Incidence, Management, and Outcome of Suspected
Continuous-Flow Left Ventricular Assist Device Thrombosis. Asaio j,
2016. 62 (1): p. 33-9.
16-Gyoten, T., et al., Identification of characteristics, risk factors,
and predictors of recurrent LVAD thrombosis: conditions in HeartWare
devices. J Artif Organs, 2021. 24 (2): p. 173-181.
17-Gyoten, T., et al., Identification of characteristics, risk factors,
and predictors of recurrent LVAD thrombosis: conditions in HeartWare
devices. Journal of artificial organs : the official journal of the
Japanese Society for Artificial Organs, 2021. 24 (2): p.
173-181.
18-Tchantchaleishvili, V., et al., Evaluation and treatment of pump
thrombosis and hemolysis. Annals of cardiothoracic surgery, 2014.3 (5): p. 490-495.
19-Jennings, D.L. and P.A. Weeks, Thrombosis in continuous-flow left
ventricular assist devices: pathophysiology, prevention, and
pharmacologic management. Pharmacotherapy, 2015. 35 (1): p.
79-98.
20-Goldstein, D.J., et al., Algorithm for the diagnosis and management
of suspected pump thrombus. J Heart Lung Transplant, 2013.32 (7): p. 667-70.
21-Webber, B.T., A.L. Panos, and Y.F. Rodriguez-Blanco, Intravenous
thrombolytic therapy for patients with ventricular assist device
thrombosis: An attempt to avoid reoperation. Annals of cardiac
anaesthesia, 2016. 19 (1): p. 192-196.
22-Nair, N., et al., Thrombolytics in VAD management - A single-center
experience. International journal of cardiology. Heart & vasculature,
2016. 11 : p. 49-54.
23-Alkhunaizi MA, Ali B. Left Ventricular Assist Device Pump Thrombosis
in a Patient Treated with Apixaban. Am J Case Rep. 2021 Dec
9;22:e934787. doi: 10.12659/AJCR.934787. PMID: 34880201; PMCID:
PMC8669518.
24-Pendyal A, Chien CV, Mudd JO, Gelow JM. Minimally Invasive LVAD
Deactivation in a 65-Year-Old Man with Recurrent Pump Thrombosis and
Left Ventricular Recovery. Tex Heart Inst J. 2017 Feb 1;44(1):70-72.
doi: 10.14503/THIJ-16-5787. PMID: 28265218; PMCID: PMC5317366.
25-Hubbert, L. , Forssell, C. , Baranowski, J. , Lindgren, B. , Holm, J.
& Ahn, H. (2017). Endovascular Stenting of a LVAD Outflow Graft
Thrombosis. ASAIO Journal, 63 (1), e3-e5. doi:
10.1097/MAT.0000000000000371.
26-Rajapreyar, I. , Acharya, D. , Tallaj, J. , Hornbuckle, L. ,
Sharpton, J. , Joly, J. & Pamboukian, S. (2019). Left Ventricular
Assist Device Thrombosis—Amiodarone-Induced Hyperthyroidism: Causal
Link?. ASAIO Journal, 65 (2), e18-e20. doi:
10.1097/MAT.0000000000000773.
27-Rajapreyar, I. , Acharya, D. , Tallaj, J. , Hornbuckle, L. ,
Sharpton, J. , Joly, J. & Pamboukian, S. (2019). Left Ventricular
Assist Device Thrombosis—Amiodarone-Induced Hyperthyroidism: Causal
Link?. ASAIO Journal, 65 (2), e18-e20. doi:
10.1097/MAT.0000000000000773.
28-Dobner S, Gräni C, Hugi-Mayr B, Mihalj M, Rhyner D, Wieser M,
Martinelli M, Hunziker L, Reineke D. Pump thrombosis and dynamic outflow
graft compression: complications in left ventricular assist device
therapy. ESC Heart Fail. 2021 Apr;8(2):1631-1636. doi:
10.1002/ehf2.13244. Epub 2021 Feb 10. PMID: 33566444; PMCID: PMC8006604.
29-Sivathasan C, Tan TE, Sim D, Kerk KL. ”Burnt out” dilated
hypertrophic cardiomyopathy causing acute LVAD thrombosis. Clin Case
Rep. 2015 Jun;3(6):376-8. doi: 10.1002/ccr3.237. Epub 2015 Apr 9. PMID:
26185632; PMCID: PMC4498846.
30-Bunge, Jeroen J. H.*,†; den Uil, Corstiaan A.*,†; Constantinescu,
Alina C.*; Budde, Ricardo P. J.‡; Maat, Alexander P. W. M.§; Caliskan,
Kadir* Acute Pump Thrombosis in the Early Postoperative Period After
HeartMate 3 Implantation, ASAIO Journal: September/October 2019 - Volume
65 - Issue 7 - p e72-e74 doi: 10.1097/MAT.0000000000000932
31-Frick WH, et al. Unusual Case of Pump Thrombosis in LVAD Patient with
COVID-19. The VAD Journal. 2020; 6(2):e2020622.https://doi.org/
10.11589/vad/e2020622.
32-Jarrett SA, et al. Left Ventricular Assist Device Thrombosis Treated
with Intravenous Tissue Plasminogen Activator in a patient with COVID-19
Infection. The VAD Journal. 2021; 7(1):e2021716.
https://doi.org/10.11589/vad/e
2021716
33-Hodges K, Mubashir M, Insler J, et al. Successful management of
COVID-19 and associated coagulopathy in a patient with durable left
ventricular assist device. J Card Surg. 2020;35(11):3202-3204.
doi:10.1111/jocs.14937.
34- Maharaj V, Steiner M, Boyle B, Kazmirczak F, Markowitz J, Alexy T,
Shaffer A, John R, Martin CM, Cogswell R, Kamdar F. Rapidly Progressive
Left Ventricular Assist Device Outflow Graft Thrombosis Associated With
COVID-19 Infection. Circ Heart Fail. 2021 Dec;14(12):e008334. doi:
10.1161/CIRCHEARTFAILURE.121.008334. Epub 2021 Nov 15. PMID: 34775782.
35-Zakrzewski J, Coyle L, Aicher T, Chickerillo K, Gallagher C, Kuper K,
Sciamanna C, Chau VQ, Tatooles A. Impact of COVID-19 on Patients
Supported with a Left Ventricular Assist Device. ASAIO J. 2021 Nov
1;67(11):1189-1195. doi: 10.1097/MAT.0000000000001578. PMID: 34475334;
PMCID: PMC8555883.
36- Birati, Edo Y et al. “Characteristics and Outcomes of COVID-19 in
Patients on Left Ventricular Assist Device Support.” Circulation. Heart
failure vol. 14,4 (2021): e007957.
doi:10.1161/CIRCHEARTFAILURE.120.007957